And its not who you might expect.
And some American companies are in the cross-fire.
Merck announces a spin-off of its lower-growth assets. Spin-offs, once a popular strategy, haven’t performed as well of late.
And Bombardier is shedding assets to stay ahead of debt payments.
And DJ D-Sol is ready to tell you all about Goldman’s new initiatives.
But if the past is any indication, the vaccine for Coronavirus may not arrive on time.